LT - Molekulės, kurios selektyviai aktyvina reguliacines T ląsteles, skirtos autoimuninių ligų gydymui
EN - MOLECULES THAT SELECTIVELY ACTIVATE REGULATORY T CELLS FOR THE TREATMENT OF AUTOIMMUNE DISEASES
Legal status
Patent lapsed (non-payment of fees)
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
C07K 14/55 |
(2006.01) |
|
|
A61K 38/00 |
(2006.01) |
|
|
C07K 16/00 |
(2006.01) |
European patent
| (11) |
Number of the document |
3172227 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
15824955.7 |
|
Date of filing the European patent application |
2015-07-20 |
| (97) |
Date of publication of the European application |
2017-05-31 |
| (45) |
Date of publication and mention of the grant of the patent |
2019-09-04
|
| (46) |
Date of publication of the claims translation |
2020-02-10
|
PCT application
| (86) |
Number |
PCT/US2015/041177 |
|
Date |
2015-07-20 |
PCT application publication
| (87) |
Number |
WO 2016/014428 |
|
Date |
2016-01-28 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
201461999241 P |
2014-07-21
|
US |
Inventors
| (72) |
GREVE, Jeffrey, US
|
Grantee
| (73) |
Delinia, Inc.,
400 Technology Square 10th Floor, Cambridge, Massachusetts 02139,
US
|
Attorney or representative
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
Title
| (54) |
Molekulės, kurios selektyviai aktyvina reguliacines T ląsteles, skirtos autoimuninių ligų gydymui |
| |
MOLECULES THAT SELECTIVELY ACTIVATE REGULATORY T CELLS FOR THE TREATMENT OF AUTOIMMUNE DISEASES |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2023-07-03 |
9 |
208.00
EUR
|
Legal status
|
Patent lapsed (non-payment of fees)
|
|
|
Invalidation date |
2024-07-20 |
